tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

HUMA Stock Latest News

Humacyte Receives FDA Approval for SYMVESS Launch
Company AnnouncementsHumacyte Receives FDA Approval for SYMVESS Launch
13m ago
8K
HUMA
FedEx to separate Freight unit, Nike reports Q2 beat: Morning Buzz
PremiumThe Fly
FedEx to separate Freight unit, Nike reports Q2 beat: Morning Buzz
5h ago
X
BB
Humacyte price target raised to $15 from $12 at H.C. Wainwright
PremiumThe Fly
Humacyte price target raised to $15 from $12 at H.C. Wainwright
11h ago
HUMA
Humacyte announces FDA approval for Symvess
PremiumThe Fly
Humacyte announces FDA approval for Symvess
12h ago
HUMA
Shareholder Alert for Humacyte, Inc. (NASDAQ:HUMA)
PremiumMarket News
Shareholder Alert for Humacyte, Inc. (NASDAQ:HUMA)
15d ago
HUMA
Humacyte announces publication of results on ATEV
PremiumThe FlyHumacyte announces publication of results on ATEV
29d ago
HUMA
HUMA LAWSUIT ALERT: Levi & Korsinsky LLP Notifies Humacyte, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
Premium
Class Action
HUMA LAWSUIT ALERT: Levi & Korsinsky LLP Notifies Humacyte, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
1M ago
HUMA
Spirit enters into bankruptcy proceedings, CVS names new directors: Morning Buzz
Premium
The Fly
Spirit enters into bankruptcy proceedings, CVS names new directors: Morning Buzz
1M ago
GS
TH
Humacyte’s sdATEV device shows efficacy in artery bypass trial in primates
PremiumThe Fly
Humacyte’s sdATEV device shows efficacy in artery bypass trial in primates
1M ago
HUMA
Humacyte Advances with $15M Direct Offering
PremiumCompany Announcements
Humacyte Advances with $15M Direct Offering
1M ago
8K
HUMA
Humacyte prices 2.8M shares at $5.34 in registered direct offering
PremiumThe Fly
Humacyte prices 2.8M shares at $5.34 in registered direct offering
1M ago
HUMA
Humacyte Faces Financial Uncertainty: Potential Impact on Share Price and Capital
PremiumCompany Announcements
Humacyte Faces Financial Uncertainty: Potential Impact on Share Price and Capital
1M ago
HUMA
Humacyte Reports Q3 2024 Results Amid FDA Review
PremiumCompany AnnouncementsHumacyte Reports Q3 2024 Results Amid FDA Review
1M ago
HUMA
Humacyte reports Q3 EPS (33c), consensus (25c)
Premium
The Fly
Humacyte reports Q3 EPS (33c), consensus (25c)
1M ago
HUMA
Humacyte price target raised to $12 from $6 at H.C. Wainwright
Premium
The Fly
Humacyte price target raised to $12 from $6 at H.C. Wainwright
2M ago
HUMA
Humacyte announces reuslts from V007 Phase 3 trial of ATEV in AV
PremiumThe Fly
Humacyte announces reuslts from V007 Phase 3 trial of ATEV in AV
2M ago
HUMA
Humacyte to host KOL event on he use of ATEV for AV access in hemodialysis
PremiumThe Fly
Humacyte to host KOL event on he use of ATEV for AV access in hemodialysis
2M ago
HUMA
Hertz Global Holdings call volume above normal and directionally bullish
PremiumThe Fly
Hertz Global Holdings call volume above normal and directionally bullish
2M ago
HUMA
Unusually active option classes on open October 18th
PremiumThe Fly
Unusually active option classes on open October 18th
2M ago
MP
PG
Humacyte issues raised in 483 appear ‘fixable,’ says BTIG
PremiumThe FlyHumacyte issues raised in 483 appear ‘fixable,’ says BTIG
2M ago
HUMA
Humacyte facility inspection likely not root cause of BLA delay, says TD Cowen
Premium
The Fly
Humacyte facility inspection likely not root cause of BLA delay, says TD Cowen
2M ago
HUMA
Humacyte concerns raised in 483 not that big a deal, says Piper Sandler
Premium
The Fly
Humacyte concerns raised in 483 not that big a deal, says Piper Sandler
2M ago
HUMA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >